Document Detail

Octreotide enhances the sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro.
MedLine Citation:
PMID:  22977639     Owner:  NLM     Status:  Publisher    
The present study aimed to investigate the effects of octreotide (OCT) on the reversal of resistance of cisplatin-resistant cancer cells and on enhancement of the cisplatin sensitivity of cancer cells. The 3-(4,5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide method and flow cytometry were used to investigate the effect of cisplatin, OCT or the combination of these two compounds on the proliferation and apoptosis of SKOV3/DDP cells. Real-time, quantitative RT-PCR was used to detect the mRNA expression of SSTR2, MDR1, MRP2, GST-π and EGFR in SKOV3/DDP cells following OCT treatment. At the concentration of 2.5-20 μg/ml, OCT significantly reduced the IC(50) value (P<0.05) and promoted apoptosis (P<0.05) in the SKOV3/DDP cells in response to cisplatin. The synergistic effect of OCT and cisplatin on SKOV3/DDP cell proliferation was observed. SSTR2 was expressed on the SKOV3/DDP cell surface. OCT increased GST-π expression (P<0.05) and reduced MRP2 and EGFR expression (P<0.05) in a dose-dependent manner. However, it had no effect on the expression of MDR1 (P>0.05). It is suggested that OCT inhibits ovarian cancer proliferation and promotes apoptosis, via the cell surface expression of SSRT2, and reverses cisplatin resistance through the inhibition of MRP2 and EGFR expression.
Yang Shen; Mulan Ren; Yuehua Shi; Yunxia Zhang; Yunlang Cai
Related Documents :
23410519 - A common microrna signature consisting of mir-133a, mir-139-3p, and mir-142-3p clusters...
25109899 - Kpna2 is a promising biomarker candidate for esophageal squamous cell carcinoma and cor...
23563499 - Fabrication of a multi-layer three-dimensional scaffold with controlled porous micro-ar...
25044209 - Turmeric toxicity in a431 epidermoid cancer cells associates with autophagy degradation...
23331159 - Label free impedance detection of cancer cells.
23519249 - Microrna mir-491-5p targeting both tp53 and bcl-xl induces cell apoptosis in sw1990 pan...
1149039 - The pancreatic epithelial cell in vitro: a possible model system for studies in carcino...
25098609 - Gbp1 is one of the key molecules contributing to cancer cell radioresistance.
9242269 - Anticipatory time intervals of head-direction cells in the anterior thalamus of the rat...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-8-11
Journal Detail:
Title:  Experimental and therapeutic medicine     Volume:  2     ISSN:  1792-1015     ISO Abbreviation:  Exp Ther Med     Publication Date:  2011 11 
Date Detail:
Created Date:  2012-9-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101531947     Medline TA:  Exp Ther Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1171-1176     Citation Subset:  -    
Department of Obstetrics and Gynecology, Zhongda Hospital, Southeast University, Nanjing 210009, P.R. China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Novel sequence variants and common recurrent polymorphisms of BRCA2 in Sri Lankan breast cancer pati...
Next Document:  Changes in serum thymidine kinase 1 levels during chemotherapy correlate with objective response in ...